Correction to: Sulodexide in the Treatment of Chronic Venous Insufficiency: Results of the All-Russian Multicenter ACVED
- PDF / 177,510 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 17 Downloads / 191 Views
CORRECTION
Correction to: Sulodexide in the Treatment of Chronic Venous Insufficiency: Results of the All-Russian Multicenter ACVEDUCT Program Andrey V. Chupin . Sergey E. Katorkin . Ivan I. Katelnitsky . Oksana V. Katelnitskaya . Igor I. Prostov . Alexey S. Petrikov . Alexander P. Koshevoi . Larisa F. Lyudkova
Published online: August 30, 2020 Ó Springer Healthcare Ltd., part of Springer Nature 2020 Correction to: Adv Ther (2020) 37:2071–2082 https://doi.org/10.1007/s12325-020-01270-9
In the original article, the ‘‘Duration, Types of Therapy and Dynamics of Improvements’’ topic published incorrectly. The correct version is ‘‘The number of doctor visits for patients according to the protocol ranged from 3 to 5 (mean ± SD 3.6 ± 0.8 visits). The mean ± SD duration of sulodexide therapy The original article can be found online at https://doi. org/10.1007/s12325-020-01270-9. A. V. Chupin (&) Federal Scientific Clinical Centre of the Federal Medical and Biological Agency of Russia, Moscow, Russia e-mail: [email protected] S. E. Katorkin Samara State Medical University of the RF Ministry of Public Health, Samara, Russia I. I. Katelnitsky O. V. Katelnitskaya I. I. Prostov Rostov State Medical University of the RF Ministry of Public Health, Rostov, Russia A. S. Petrikov Altai State Medical University of the RF Ministry of Public Health, Barnaul, Russia A. P. Koshevoi Clinic ‘‘SibMedCentre’’, Tomsk, Russia L. F. Lyudkova Krasnoyarsk Interregional Polyclinic No 1, Krasnoyarsk, Russia
was 46.8 ± 13.1 days. The duration of therapy increased with CEAP class, from 29.9 ± 14.5 days in patients with C1 to 48.9 ± 13.8 days in those with C6. The majority of patients (63%; n = 1417) visited the doctor three times and used parenteral and oral formulations of sulodexide (85%; n = 1203) during the treatment period. Of the remaining 214 patients, 170 (71%) only received sulodexide orally and 44 (29%) only received the drug parenterally’’.
Data Loading...
